v3.26.1
Segment information
12 Months Ended
Dec. 31, 2025
Segment information  
Segment information

6. Segment information

We currently operate as a single operating segment.

GEOGRAPHICAL INFORMATION

In 2023, 2024 and 2025, our continuing operations were mainly located in Belgium, France, the Netherlands, Switzerland and United States. The revenues from our collaboration partner Gilead represented 97% of our total net revenues from continuing operations in 2025 (87% in 2024, nearly 100% in 2023). The remaining 3% of the net revenues in 2025 (13% in 2024) consisted of supply revenues of Jyseleca® products to Alfasigma (Italy). The revenues in the country of domicile of Galapagos NV (Belgium) are not material.

Following table summarizes the net revenues by destination of customer:

Year ended December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

(Euro, in thousands)

United States of America

1,081,144

266,588

665,174

Europe

31,104

46,577

118,354

Total net revenues

1,112,248

313,165

783,528

minus:

United States of America

25,802

425,466

Europe

11,714

118,338

Total net revenues from discontinued operations

37,516

543,804

United States of America

1,081,144

240,786

239,708

Europe

31,104

34,863

16

Total net revenues from continuing operations

1,112,248

275,649

239,724

On December 31, 2025, we held €81.5 million of property, plant and equipment, intangible assets and goodwill (€357.8 million in 2024; €323.8 million in 2023) distributed as follows:

December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

(Euro, in thousands)

Belgium

3,887

95,686

56,209

France

5

1,438

The Netherlands

75,890

239,454

251,230

Switzerland

92

3,247

United States of America

1,734

22,533

11,660

Total non-current assets

81,511

357,770

323,784